Cutaneous CD30+ cells in children with atopic dermatitis

Area of Science:

• Immunology
• Dermatology
• Pediatrics

Background:

• CD30 is a marker of T helper 2 (Th2) cells.
• Atopic dermatitis (AD) is a common inflammatory skin condition in children.
• Investigating CD30+ cells in AD skin lesions and their relation to systemic markers is crucial.

Purpose of the Study:

• To investigate the presence of CD30+ cells in the lesional skin of children with atopic dermatitis (AD).
• To analyze the relationship between CD30+ cells and serum soluble CD30 (sCD30) levels, IgE, soluble interleukin-2 receptor (sIL-2R), and soluble CD23 (sCD23).
• To correlate these findings with clinical scores in AD patients.

Main Methods:

• Studied 10 children with AD, 9 age-matched controls, and adults.
• Assessed clinical severity using the SCORAD index.
• Measured serum levels of IgE, sCD30, sIL-2R, and sCD23.
• Performed skin biopsies for CD30+ cell analysis and skin prick tests (SPTs).

Main Results:

• High proportions of CD30+ cells were found in AD skin biopsies.
• Children with AD showed significantly elevated serum IgE, sCD30, sIL-2R, and sCD23 compared to controls.
• CD30+ cells did not correlate with serum IgE, sCD30, sIL-2R, sCD23, SPT results, or clinical scores.

Conclusions:

• Children with AD exhibit significant numbers of CD30+ cells in lesional skin and elevated serum sCD30.
• CD30+ cells in AD skin lesions do not correlate with systemic markers of IgE-mediated allergic reactions.